For instance, in April 2023, China-based Peking Union Medical College Hospital initiated a clinical trial to evaluate the efficacy and safety of lenalidomide in the treatment of oral ulcers in adult ...

Behçet disease is a chronic multisystem inflammatory disorder with oral and genital ulcers present in up to 95% of patients ... images with minimal references is required. The patient’s written ...

Adding to the high stakes of oral arguments, Bruland will be the first associate from the top AmLaw200 firm to present his case before the most prominent justices in the country. "It's been ...

Canada and the European Union for the treatment of oral ulcers associated with Behçet’s disease. This study is the first to confirm that the clinical benefits of apremilast in reducing the number and ...

Background Bechet’s disease (BD) is a chronic inflammatory multisystem disease characterised by recurrent oral and genital aphthous ulcers, uveitis and skin lesions ... Soy M, Erken E, Konca K, et al.

Apremilast (Otelza, Amgen), a phosphodiesterase-4 inhibitor approved by the FDA for treating oral ulcers in Behçet’s syndrome, has also shown potential benefits for other clinical ...

Introduction Evidence from randomised controlled trials on anti-tumour necrosis factor (TNF) agents in patients with Behçet’s syndrome (BS ... manifestations (presence of recurrent oral ulcers and/or ...

and oral ulcers associated with Behcet’s disease. As a pill that treats all severities of plaque psoriasis, it is the first and only approved oral treatment of its kind, and it is the only ...

Background Behçet’s disease is a rare immune-mediated disorder that can affect the gastrointestinal tract. The prevalence and extension of small bowel involvement is largely unknown. Objective The aim ...